Linkage analysis has revealed a number of gene intervals conferring susceptibility to developmental dyslexia-a language-based learning disability affecting 4 -10% of the population. Recently, candidate dyslexia susceptibility genes (CDSGs) have been proposed at some of these intervals, including MRPL19 and C2ORF3 on Chr 2 (Anthoni et al., 2007) , ROBO1 on Chr 3 (Hannula-Jouppi et al., 2005) , DCDC2 and KIAA0319 on Chr 6 Cope et al., 2005; Meng et al., 2005; Schumacher et al., 2006) , DYX1C1 on Chr 15 (Taipale et al., 2003; Brkanac et al., 2007; Marino et al., 2007 ; but see also Scerri et al., 2004; Bellini et al., 2005; Marino et al., 2005) . We have previously demonstrated that embryonic knockdown of Dcdc2, Kiaa0319, or Dyx1c1 function in the rat disrupts the process of neuronal migration to the cerebral cortex, as assessed during the prenatal period (Meng et al., 2005; Paracchini et al., 2006; . Recent evaluation of the postnatal consequences of embryonic knockdown of Dyx1c1 function in rats revealed the presence of a variety of neocortical malformations, including molecular layer ectopias and periventricular heterotopias (PVHs) .
The potential role of these genes in neuronal migration is intriguing when considered in light of previous evidence demonstrating the presence of neuronal migration disorders in the brains of dyslexics (Galaburda and Kemper, 1979; Galaburda et al., 1985; Humphreys et al., 1990) , which consist of nests of neurons and glia in the molecular layer (ectopias), intracortical laminar dysplasias, and occasional instances of focal microgyria. In addition, there is a reported increased incidence of developmental dyslexia in patients with periventricular nodular heterotopias (Chang et al., 2005; Sokol et al., 2006) . Taken together, these results suggest that disruption of the function of any of these CDSGs may underlie the anatomic phenotype of this disorder.
Of the CDSGs currently reported, the strongest support has been given for DCDC2 and KIAA0319 on Chr 6 Cope et al., 2005; Meng et al., 2005; Harold et al., 2006; Paracchini et al., 2006; Schumacher et al., 2006) . In the original report identifying DCDC2 as a CDSG, in utero electroporation of small hairpin RNA (shRNA) targeted against the rat homolog of this gene was shown to disrupt neuronal migration when assessed 4 -7 days after transfection (Meng et al., 2005) . What is not known is the postnatal phenotype of this embryonic knockdown. Here we examine the brains of postnatal rats where Dcdc2 was either knocked down (using shRNA) or overexpressed during cerebral cortical development. We find that knockdown, but not overexpression, of Dcdc2 results in neocortical malformations in the cerebral cortex.
EXPERIMENTAL PROCEDURES

In situ hybridization
In order to better interpret the knockdown and overexpression findings, we first determined the expression of Dcdc2 in the prenatal brain by in situ hybridization. We obtained time-mated pregnant females (Charles River Laboratory, Wilmington, MA, USA) and killed the litters on embryonic day (E) 15, E17 or E19. Three embryos from each litter were immediately frozen and they were cut in either the horizontal, sagittal, or coronal plane on a cryostat at 18 m, and the slides were processed for in situ hybridization of Dcdc2 as described below.
The cDNA prepared from frontal, parietal, and occipital lobes of human embryonic brain (20 weeks, Biochain Institute, Hayward, CA, USA) was amplified with respective forward (ATGAGCGGCAG-CAGCGCCAGG) and reverse primers (CTAAGCCACGGCAGCAT-AGTCC) for 35 cycles. All fragments were then cloned into t vector (Invitrogen, Carlsbad, CA, USA) and sequenced to verify Dcdc2 amplification. Rat embryonic and postnatal brain cDNAs were synthesized from total RNA and amplified with the primers (Forwardϭ ATGAACGGTCCCAGCCCCAGG; ReverseϭCTATGCCACAGC-AGAAGAGGCTT) to rat Dcdc2. The amplified DNA was gel-purified, cloned, and sequence verified to be Dcdc2. Nonradioactive in situ hybridizations were done by UB-In Situ (Natick, MA, USA), as previously described (Berger and Hediger, 2001 ), using a digoxigeninlabeled cRNA probe. The antisense and sense probes were obtained from the polymerase chain reaction (PCR) products, amplified from rat E14 brain cDNA, and cloned in pGEMT-Easy (Promega Corp., Madison, WI, USA) flanking T7 and SP6 promoters. Two probes, one from the first 400 bp generated from PCR primer pairs and the second full-length cDNA yielded similar results.
In utero electroporation
In utero electroporation was performed at the University of Connecticut and all procedures were approved by the Institutional Animal Care and Use Committee of that institution. All experiments conformed to international guidelines on the ethical use of animals. All attempts were made to reduce the number of animals used and their suffering.
Five pregnant Wistar rats were obtained (Charles River Laboratory) and each litter was assigned to one of five conditions: Dcdc2 shRNA, Rescue, DCDC2 Overexpression, DCDC2-DCX Domain Overexpression, or DCDC2-C Terminal Domain Overexpression (see Table 1 ). Within each litter, pups were randomly assigned to receive one of two treatments: Treatment 1 was the "experimental" construct (shRNA or Overexpression) and treatment 2 was a "control" construct (scrambled shRNA, Rescue, or fluorescent protein only). This design was essential for the analysis of migrational distance as it controlled for between-litter variation in gestational age. In utero electroporation of plasmid DNA was performed at E15 as described previously (Bai et al., 2003; Rosen et al., 2007) . Concentrations of GFP and RFP plasmids were 0.5 g/L, the shRNA was 1.5 g/L, and overexpression plasmids were 2.0 g/L.
Plasmids
For the Dcdc2 shRNA condition, plasmids encoding shRNA (pU6shRNA-Dcdc2A) and plasmids encoding enhanced green fluorescent protein (GFP) (pCAGGS-GFP) were co-transfected into the ventricular zone (VZ). Littermates were co-transfected with plasmids encoding a scrambled version of the shRNA fused with GFP (pU6shRNA-Dcdc2 scram along with plasmids encoding monomeric red fluorescent protein (RFP) (pCAGGS-RFP) and plasmid encoding GFP. In the Rescue condition, subjects were co-transfected with pU6shRNA-Dcdc2A, a fusion construct coding for the human DCDC2 protein with GFP (pCAGGS-DCDC2-GFP), and pCAGGS-RFP. Littermates were transfected with pCAGGS-GFP. Pups in the DCDC2 overexpression group were co-transfected with pCAGGS-DCDC2-GFP and pCAGGS-RFP, and their littermates with pCAGGS-GFP. The DCDC2 DCX Domain overexpression group was transfected with pCAGGS-DCDC2 DCX domain-GFP plasmids and pCAGGS-RFP, and the remaining pups in the litter received pCAGGS-GFP. In the DCDC2 C-Terminal Domain overexpression group, pups were co-transfected with pCAGGS-DCDC2 C-Terminal-GFP and pCAGGS-RFP, and paired littermates were transfected with pCACGS-GFP. Previous research indicated that co-transfection is highly efficient .
Histology
At postnatal day 21, animals were deeply anesthetized (ketamine/ xylazine 10:1, 100 mg/mL) and killed by transcardial perfusion with 0.9% saline followed by 4% paraformaldehyde. The brains were removed from the skull and were coronally sectioned at 80 m on a vibratome. Sections were then mounted and coverslipped with Vectashield Mounting Medium (Vector Laboratories, CA, USA) and visualized under fluorescence for the presence of GFP and/or RFP. One series of every tenth section was stained for Nissl substance using Thionin. One adjacent series of freefloating sections was processed for immunohistochemical detection of GFP (Chemicon, 1:200) using ABC protocols. Adjacent series in some brains were processed for immunofluorescence detection of Cux-1 (CDP (M-222), Santa Cruz Biotechnology, CA, USA, 1:1000)-a transcription factor that labels supragranular neurons in the cerebral cortex (Nieto et al., 2004 )-with Alexa Fluor 594 secondary antibody (Invitrogen, 1:200) .
Analysis
In situ quantification. Individual sense and antisense sections from horizontally prepared brains (one each from E15, E17, and E19 rats) were imaged with a monochrome digital camera (Insight, Diagnostic Instruments, Sterling Heights, MI, USA) on a light box (Aristo Grid Lamp Products, Waterbury, CT, USA) and interfaced via firewire to Macintosh G4 computer (Apple Com- Table 1 . Summary of litter treatments (N used for migration analysis/Total N)
puter, Cupertino, CA, USA). Each antisense section image and its corresponding sense section were captured using SPOT software (Diagnostic Instruments) with common exposure settings. Using ImageJ (http://rsb.info.nih.gov/ij/), optical density values were measured for the combined cortical plate and ventricular zone. A total of 9 to 13 sections were measured for each brain. The average difference in optical density between sense and antisense images was computed and expressed as a percent of sense density.
Postnatal analysis. All analyses of postnatal brains were performed blind with respect to condition. Nissl-stained sections were surveyed for the presence of neocortical and/or hippocampal malformations, and the location was noted. Quantitative analysis of migrational distance was conducted as previously described . Briefly, the location of immunohistochemically labeled cells was charted in the immunohistochemically stained series using Neurolucida (MBF Biosciences, Williston, VT, USA). These were then imported into Canvas X (ACD Systems, Miami, FL, USA), and a counting rectangle subdivided into 10 equal-size bins was scaled to extend from the white matter to the pial surface. The number of labeled cells within each decile was manually counted and recorded. For each brain, the rectangle was arbitrarily placed in the transfected hemisphere from the four to eight sections. The percentage of labeled cells in each decile was determined for each animal, and the mean value across all animals within each condition was determined. Differences in the distribution of migrated neurons across deciles were assessed using repeated measures analysis of variance.
Image processing
Fluorescent images were obtained on a confocal microscope (Zeiss LSM 510 Meta, Carl Zeiss, Inc., Thornwood, NY, USA). Photomicrographs were adjusted for exposure and sharpened (unsharp mask filter) using Adobe Photoshop (Adobe Inc., San Jose, CA, USA). Some images were acquired using the Virtual Slice Module of Neurolucida. Image montages were created in Canvas X.
RESULTS
Dcdc2 is ubiquitously expressed at a modest level in the forebrain
In situ hybridization of Dcdc2 in embryonic rat embryos revealed relatively ubiquitous expression in the forebrain during development (Fig. 1A-F) . Overall, expression is modest throughout the brain. Quantification of expression in the combined cortical plate and ventricular zone demonstrated an approximately twofold increase in optical density in the antisense sections at E15. In comparison, there was an approximately 0.6-fold increase in optical density at E17 and E19. These results are mostly compatible with those of Reiner et al. (2006) , who found limited expression of Dcdc2A in the brains of mice at E14.5.
PVHs are present only in Dcdc2 shRNA transfected subjects
For the purposes of qualitative analysis, the Dcdc2 shRNA-treated rats from litters 1 and 2 were combined. Examination of the Nissl-stained sections revealed what we term PVHs, which reflects both nodular heterotopias and heterotopias in the white matter, in seven of eight Dcdc2 shRNA-treated rats ( Fig. 2A, B , E, F). PVH consisted of large collections of neurons within the white matter, or at the cortical/white matter border that were visible on Nissl-and immunohistochemically-stained sections.
In order to determine the specificity of the RNAi for Dcdc2 we performed experiments in which the Dcdc2 shRNA was co-transfected with a plasmid encoding human DCDC2 (pCAGGS-DCDC2-GFP). Human DCDC2 nucleotide sequence does not match rat Dcdc2 sequence in the region targeted by the Dcdc2 shRNA and therefore is not susceptible to RNAi. Of the rats simultaneously transfected with Dcdc2 shRNA and the human DCDC2 overexpression construct, one of four had a small (Ͻ10) collection of heterotopic neurons clustered together on one section (three of these neurons were GFP-positive). The remainder had no obvious malformations (Fig. 2C, D) . This suggests that overexpressing the human DCDC2 protein in Dcdc2 shRNA-treated rats rescued the PVH phenotype, and indicates that the effects of the RNAi are not due to off target effects. None of the rats in other treatment groups had PVH.
In the Dcdc2 shRNA condition, only a subset of the neurons in the PVH was immunopositive for GFP, indicating that there were large numbers of ectopic neurons that had not been transfected with Dcdc2 shRNA. Because the efficiency of co-transfection is nearly 100% , this suggests that there are non cell-autonomous effects of Dcdc2 shRNA transfection. Those cells that were immunopositive for GFP were clearly neuronal in morphology, but their normal radial orientation was disturbed (Fig. 2E, F, G) .
Immunostaining for Cux-1, a transcription factor uniquely expressed in supragranular layers (Nieto et al., 2004) , revealed large numbers of Cux-1 positive neurons in the PVH (Fig. 3) . Of the shRNA-transfected neurons throughout the cerebral cortex, most were Cux-1 positive. The presence of numerous non-transfected Cux-1 positive neurons in the PVH again supports the contention that there are non-cell autonomous effects of Dcdc2 shRNA transfection.
Malformations of the hippocampus
There were hippocampal malformations in two of eight Dcdc2 shRNA-treated rats (see Fig. 4A, B) . These malformations consist of cells originally from the pyramidal layer localized in the stratum radiatum and stratum oriens (see Fig. 4A , B), and were not associated with the injection site.
Comparison between immunostained and adjacent Thionin-stained sections revealed that only a small percentage of the ectopic neurons stained positively for GFP (Fig.  4A=) . As with the PVH discussed above, this suggested non-cell autonomous effects in the hippocampus of Dcdc2 shRNA transfection. Of the remaining rats in the experiment, there were three (two GFP controls and one Dcdc2 DCX domain overexpression group) that exhibited more modest malformations of the hippocampus (Ͻ5 mismigrated neurons), but they were associated with the injection site and were likely artifactual. 
Dcdc2 shRNA-transfected neurons migrate in a bimodal pattern
Migration distance analysis was performed within each group using a repeated measure ANOVA with Treatment (1 vs. 2) as the between, Deciles as the within, and the percent of neurons within each decile as the dependent measure. In group 1 (Fig. 5A, B) , there was a significant TreatmentϫDecile interaction (F 9,45 ϭ3.9, PϽ0.05), indicating that the laminar dispersion of Dcdc2 shRNA-transfected neurons significantly differed from those of neurons transfected with the mutant form of Dcdc2. Further analysis revealed that there were significantly more Dcdc2 shRNA-transfected neurons in the lower four deciles (F 3,15 ϭ4.9, PϽ0.05) and a significantly greater number of these neurons that migrated past the expected lamina (F 9,45 ϭ3.9, PϽ0.05).
In group 2, the Dcdc2 shRNAϩpCAGGS-DCDC2-GFP condition, there was no significant difference in the distribution of transfected neurons between the treatments (F 6,30 Ͻ1, NS). This suggested that the treatment of shRNA-transfected neurons with the DCDC2 overexpression construct failed to rescue this migration phenotype. Although there appeared to be a mild arrest of migration in animals transfected with either the DCDC2 overexpression construct (Fig. 5E, F) or the C terminal domain (Fig. 5I, J) , there were no significant differences in laminar dispersion of the transfected neurons between groups 3, 4, or 5 (F 9,36 ϭ1.3, NS; F 9,54 Ͻ1, NS; F 9,44 ϭ1.9, NS; respectively) ( Fig. 5E-J) .
DISCUSSION Embryonic knockdown of Dcdc2 function is associated with neocortical malformations
Previous work showed that the embryonic knockdown of Dcdc2 function in neocortical progenitor cells by transfection with shRNA resulted in a disturbance in neuronal migration when assessed 4 -7 days post-transfection. Here, we demonstrate that this disruption of neuronal migration results in malformations that can be seen in the postnatal cerebral cortex. Specifically, we found PVHs in the brains of animals transfected with shRNA targeted against Dcdc2. These heterotopias, which are apparent in Nissl-stained sections, are located at the neocortical/white matter border, and are composed of both transfected and non-transfected neurons. Moreover, large numbers of these non-transfected neurons were Cux-1 positive, suggesting that they were neurons destined for supragranular layers whose migration was halted by non-cell autonomous effects of Dcdc2 shRNA treatment. Co-transfection of Dcdc2 shRNA with the DCDC2 overexpression construct mostly rescued this phenotype, as there was only one small collection of heterotopic neurons noted in this group. There were no PVHs in any of the rats from the three overexpression conditions. Taken together, this supports the claim that PVHs are the result of the knockdown of Dcdc2 function. 
Dcdc2 and neuronal migration
The specific function of Dcdc2 in neuronal migration has yet to be elucidated, but analysis of its protein structure provides some clues. DCDC2 is one of an 11-member group of proteins distinguished by the presence of tandem or single dcx domains. DCX, the first gene of this family to be characterized, was identified after the discovery of mutations in a gene that caused double cortex syndrome and lissencephaly in humans (Allen et al., 1998 , des Portes et al., 1998 . The dcx domain appears critical for binding to and stabilizing microtubules and is regulated by phosphorylation (Gleeson et al., 1999; Graham et al., 2004; LoTurco, 2004; Reiner et al., 2004; Schaar et al., 2004) . More recently another member of the DCX family, Dclk, has been shown to genetically interact with Dcx in mice, and functional knockdown of either of these genes results in the interruption of normal neuronal migration in neocortex. Interestingly, two functioning copies of Dcx and Dclk appear to be necessary both for growth of axons across the corpus callosum as well as for neuronal migration in cerebral cortex (Deuel et al., 2006; Koizumi et al., 2006; Friocourt et al., 2007) . A comparison of the biochemical and cellular functions of proteins in the Dcx family found that Dcdc2 exhibits the same functional features shown by Dclk and Dcx , and analysis suggests that DCX, DCDC2, and DCLK are the most conserved genes in this superfamily .
RNAi of DCX and Dcdc2 leads to qualitatively different impairments in migration, however, indicating that their roles in migration are distinct. Whereas RNAi of DCX leads to large continuous subcortical band heterotopia, RNAi of Dcdc2 leads to smaller isolated PVH. DCDC2 may act earlier in the migration path for migrating cells than does DCX because PVH occur nearer to the ventricles than subcortical band heterotopias do. Another striking difference between DCX and DCDC2 RNAi is that DCX RNAi does not lead to cells that overmigrate, and instead causes a general impairment of all migration to upper layers (Bai et al., 2003; Ramos et al., 2006) . This difference suggests that DCDC2, unlike DCX, also functions in the normal termination of migration. Fig. 3 . Confocal microscopy of the laminar specific transcription factor Cux-1 in the brain of rats embryonically transfected with shRNA targeted against Dcdc2. Top row illustrates high density of Cux-1 immunoreactive neurons in layers 2/3 as expected. Neurons transfected with Dcdc2 shRNAϩGFP are co-labeled with Cux-1 (arrows). Scale barϭ25 m. Middle row illustrates a single neuron in layer 5 that was transfected with Dcdc2 shRNAϩGFP and is co-labeled with Cux-1. Scale barϭ25 m. Bottom row is large PVH that contains numerous Cux-1 positive neurons (arrows and arrowheads), only a small subset of which are co-labeled with GFP (arrows). Nuclei are counterstained with DAPI. Scale barϭ50 m.
Overexpression of DCDC2 does not affect neuronal migration
The initial report identifying DCDC2 as a CDSG did not offer evidence as to the functional consequences of the specific polymorphisms linked to the behavioral phenotype (Meng et al., 2005) . It could be, therefore, that the DCDC2 gene variants result in either overexpression or knockdown of the DCDC2 protein. The results reported here confirm the initial reports that knockdown of Dcdc2 expression via shRNA in neocortical progenitor cells disrupts neuronal migration to the cerebral cortex (Meng et al., 2005) . Overexpression of DCDC2, however, does not significantly impair neuronal migration. Thus, there were no cerebral cortical malformations in rats embryonically transfected with plasmids encoding either the full DCDC2 protein, or the C terminal or DCX domain. Although overexpression of the DCDC2 protein or the C terminal domain appeared to mildly arrest migration (see Fig.  5E , F, I, J), there was not a statistically significant disruption of laminar disposition comparable to that seen in following embryonic transfection with Dcdc2 shRNA. Taken together, these results do not provide support for the role of DCDC2 overexpression in the neuronal migration. This does not discount, however, the possibility that DCDC2 overexpression may affect other anatomic, physiologic, or behavioral phenotypes. These possibilities are being addressed in ongoing experiments.
Laminar organization is disrupted following Dcdc2 shRNA transfection
Migration distance analysis revealed that Dcdc2 shRNAtransfected neurons migrated in a bimodal pattern, with peaks at the white matter border and upper laminae. Those neurons in the upper laminae migrated past their expected location when compared with their control littermates. This is a similar pattern to that seen following Dyx1c1 shRNA transfections, and is discussed in detail elsewhere ). In the current experiment, however, we found that there was no significant difference in the laminar disposition of neurons between rats transfected with Dcdc2 shRNA and those co-transfected with Dcdc2 shRNA and the DCDC2 overexpression construct. Specifically, while a few neurons remained along the white matter border with the cerebral cortex in the "rescue" condition, the majority of the neurons migrated past the expected lamina.
The lack of rescue of this migration phenotype could indicate that "overmigration" is the result of an off-target effect of the Dcdc2 shRNA. Or, it could be the case that the human DCDC2 overexpression construct was not effective because of the slight differences in sequence between the human and rat. This is unlikely, however, since we have shown this, this construct successfully rescued the malformation phenotype. Another explanation could be that both the knockdown and overexpression constructs have the same effects on the migration distance phenotype. This does not appear to be the case, however, as transfection with the DCDC2 overexpression construct alone did not produce an overmigration phenotype, and instead transfected neurons migrated to slightly lower laminae (Fig. 5E, F) . On the other hand, there were far fewer surviving transfected neurons following Dcdc2 shRNAϩ DCDC2 overexpression treatment, when compared with their littermates who were transfected solely with Dcdc2 shRNA. This raises the possibility that co-transfection in this case was particularly toxic to the cells, and that those neurons that survive comprise a special population that is atypical. The stoichiometry of the knockdown and overexpression constructs is not known at this time, and it could be that the timing of their expression in the cell may prove important in understanding this phenomenon. At the very least, we cannot exclude the possibility that this overmigration phenotype is the consequence of some as yet undefined off-target effect of Dcdc2 shRNA treatment. 5 . Patterns of neuronal migration to the cerebral cortex in each of the five experimental groups. First column contains plots of GFP-positive neurons in the cerebral cortex of rats exposed to Treatment 1 (the "experimental" condition). The second column contains plots from Treatment 2 ("control" condition). The last column contains histograms representing the percent of neurons contained within each of the deciles ranging from the white matter to the pial surface. Analysis reveals significant differences in the pattern of neuronal migration only between A and B, with there being a significantly greater number of neurons in both the lower and upper deciles in the Dcdc2 shRNA group as compared with the control condition.
Comparison to knockdown of other CDSGs
Previously, we have demonstrated that embryonic knockdown of the candidate dyslexia genes Kiaa0319 and Dyx1c1 disrupted neuronal migration. In the case of both of these genes, transfected neurons were severely delayed in their migration out of the ventricular zone when assessed 4 -7 days posttransfection Wang et al., 2006) . In adulthood, we found that the disruption of neocortical migration by knockdown of Dyx1c1 function caused a variety of malformations in the forebrain similar to those reported here. For both Dyx1c1 and Dcdc2, the majority of shRNA-transfected brains examined had PVH that contained transfected and nontransfected neurons. Approximately 25% of the brains in both groups were noted to have remarkably similar hippocampal malformations. In addition, the bimodal pattern of migration of transfected neurons was similar for both Dyx1c1 and Dcdc2 shRNA groups. In both cases, approximately 7-15% of the transfected neurons failed to migrate past the white matter/neocortical border, and the peak locations of the neurons that did migrate were superficial to their expected lamina (but see above). On the other hand, there were phenotypic differences between the brains of rats embryonically transfected with Dyx1c1 or Dcdc2 shRNA. In the case of the former, there were clusters of mostly non-transfected neurons in the molecular layer of the neocortex, which were not associated with the injection site. There were no such molecular layer ectopias in the Dcdc2 shRNA-transfected brains.
The phenotypic similarities between Dyx1c1 and Dcdc2 shRNA brains could indicate that they share cellular and/or molecular pathways that are important for neuronal migration. There is no evidence as yet to directly link the function of these two genes, but previous reports suggest that Dyx1c1 is localized in the cytoplasm along microtubules , which is also the site where Dcdc2 is hypothesized to be localized. On the other hand, it could be that the phenotypes shared between these two genes are the result of a non-cell autonomous disruption of neuronal migration, while those that are unique are the result of the specific, and differential, effects of the knockdown of the gene in question. If this were the case, one would hypothesize that PVH, hippocampal malformations, and the bimodal distribution of transfected neurons would be seen following knockdown of function of any number of neuronal migration genes. As mentioned above, embryonic knockdown of Kiaa0319 via RNAi disrupts neuronal migration when assessed 4 -7 days posttransfection , and preliminary examination of these brains postnatally reveals all three phenotypes (Rosen, Galaburda, LoTurco, Burbridge, Peschansky, and Volz, unpublished observations) . On the other hand, embryonic knockdown of Dcx does not produce PVH, nor is there an overmigration phenotype (Bai et al., 2003; Ramos et al., 2006) . Dissection of the cellular and molecular consequence of the knockdown of these neuronal migration genes will help elucidate these issues.
Dyslexia candidate susceptibility genes and neuronal migration disorders
Postmortem examination of the brains of individuals with developmental dyslexia has revealed neocortical malformations (Galaburda and Kemper, 1979; Galaburda et al., 1985; Humphreys et al., 1990) . We and others have previously shown that animals with induced or spontaneously occurring malformations of the cerebral cortex have profound changes in other aspects of cerebral anatomy (Jacobs et al., 1999; Rosen et al., 2001) , connectivity (Giannetti et al., 1999 (Giannetti et al., , 2000 Jenner et al., 2000; Rosen et al., 2000) , physiology (Luhmann and Raabe, 1996; Frenkel et al., 2000; LoTurco, 2001, 2002; Jacobs and Prince, 2005) , and behavior (Fitch et al., 1994 (Fitch et al., , 1997 Peiffer et al., 2002 Peiffer et al., , 2004 ). Recent reports demonstrate that embryonic knockdown of any of three CDSG homologsDyx1c1, Kiaa0319, and Dcdc2-by transfection with shRNA disrupts neuronal migration in rats (Meng et al., 2005; Paracchini et al., 2006; Wang et al., 2006) . More recently, we have shown that embryonic knockdown of the CDSG Dyx1c1 in neocortical progenitor cells results in malformations of the cerebral cortex similar to those seen in developmental dyslexia . Moreover, these animals exhibit behavioral deficits in rapid auditory processing that are reminiscent of those reported in language-impaired individuals and in animals with induced cortical malformations . In the current experiment, we report that knockdown of function of the CDSG homolog Dcdc2 also results in neuronal migration anomalies that resemble those found in humans with developmental dyslexia, including laminar dysplasias (Galaburda et al., 1985) and periventricular nodular heterotopias (Chang et al., 2005 (Chang et al., , 2007 . Thus, of the currently identified dyslexia candidate susceptibility genes whose functions have been investigated, all appear to play a role in neural development, specifically in neuronal migration. Taken together, these results support the link between neuronal migration disorders and developmental dyslexia. Future research will consider the long term anatomic, connectional, physiological, and behavioral consequences of these genetically induced malformations.
